Influence of perinatal factors on thyroid stimulating hormone level in cord blood

Authors

1 Department of Neonatologyand, Child Growth and Development Research Center, Isfahan, Iran

2 Department of Pediatric Endocrinology, Child Growth and Development Research Center, Isfahan, Iran

3 Department of Pediatric, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Pediatric, Child Growth and Development Research Center, Isfahan, Iran

5 Department of Community Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: The aim of the present study was to determine the effect of various perinatal factors on cord blood TSH among newborns in Isfahan, Iran.
Materials and Methods: This was a descriptive-analytic cross sectional study which performed in Isfahan Iran. During a period of four months, since February to May 2012 a total number of 440 newborns delivered in Alzahra and Shahid beheshti hospitals were enrolled in the study. For all newborns one mL blood sample from umbilical vein was obtained by one of the project investigators and sent to laboratory for further examinations. Cord blood TSH and birth body weight (BBW), gestational age, history of gestational diabetes mellitus (GDM), apgar at one minute, apgar at five minute, newborn gender and the mother's age were documented. Differences considered statistically significant if P < 0.01.
Results: 440 newborns enrolled in the study, 221 (50.2%) were male and 219 (49.8%) were female. Among study parameters, method of delivery had statistically significant relation with cord blood TSH (P < 0.001), and other factors such as BBW, gestational age, GDM, apgar at one minute, apgar at five minute, newborn gender and the mother's age didn't have statistically significant relationship with cord TSH level.
Conclusion: In conclusion we deduce that the only factor that can affect cord blood TSH was method of delivery. Infant with vaginal delivery has higher TSH level in cord blood. Other factors that were evaluated in this study didn't have any statistically significant relationship.

Keywords

1. Metabolic and endocrine disorders. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Neonatal-Perinatal Medicine. Elsevier, 2011. p. 1497-620.  Back to cited text no. 1
    
2. Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab 2007;91:268-77.  Back to cited text no. 2
[PUBMED]    
3. Shamshiri AR, Yarahmadi S, Forouzanfar MH, Haghdoost AA, Hamzehloo G, Holakouie NK. Evaluation of current guthrie TSH cut-off point in Iran congenital hypothyroidism screening program: A cost-effectiveness analysis. Arch Iran Med 2012;15:136-41.  Back to cited text no. 3
    
4. Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis 2010;5:17.  Back to cited text no. 4
[PUBMED]    
5. Hashemipour M, Hovsepian S, Kelishadi R, Iranpour R, Hadian R, Haghighi S, et al. Permanent and transient congenital hypothyroidism in Isfahan-Iran. J Med Screen 2009;16:11-6.  Back to cited text no. 5
[PUBMED]    
6. LaFranchi SH. Hypothyroidism. Pediatr Clin North Am 1979;26:33-51.  Back to cited text no. 6
[PUBMED]    
7. Alm J, Hagenfeldt L, Larsson A, Lundberg K. Incidence of congenital hypothyroidism: Retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed) 1984;289:1171-5.  Back to cited text no. 7
[PUBMED]    
8. Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989;321:13-6.  Back to cited text no. 8
[PUBMED]    
9. Stephen LaFranchi. Clinical features and detection of congenital hypothyroidism. In: Denise S. Basow, editor. UpToDate. Waltham, MA: UpToDate, 2009.  Back to cited text no. 9
    
10. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290-303.  Back to cited text no. 10
    
11. Narchi HH, Kulaylat NA. Congenital hypothyroidism screening program: A five-year experience at Saudi ARAMCO Al Hasa Health Center. Ann Saudi Med 1996;16:47-9.  Back to cited text no. 11
    
12. Henry G, Sobki SH, Othman JM. Screening for congenital hypothyroidism. Saudi Med J 2002;23:529-35.  Back to cited text no. 12
[PUBMED]    
13. Hardy JD, Zayed R, Doss I, Dhatt GS. Cord blood thyroxine and thyroid stimulating hormone screening for congenital hypothyroidism: How useful are they? J Pediatr Endocrinol Metab 2008;21:245-9.  Back to cited text no. 13
[PUBMED]    
14. Manglik AK, Chatterjee N, Ghosh G. Umbilical cord blood TSH levels in term neonates: A screening tool for congenital hypothyroidism. Indian Pediatr 2005;42:1029-32.  Back to cited text no. 14
[PUBMED]    
15. Franklin RC, Carpenter LM, O'Grady CM. Neonatal thyroid function: Influence of perinatal factors. Arch Dis Child 1985;60:141-4.  Back to cited text no. 15
[PUBMED]    
16. Herbstman J, Apelberg BJ, Witter FR, Panny S, Goldman LR. Maternal, infant, and delivery factors associated with neonatal thyroid hormone status. Thyroid 2008;18:67-76.  Back to cited text no. 16
[PUBMED]    
17. Miyamoto N, Tsuji M, Imataki T, Nagamachi N, Hirose S, Hamada Y. Influence of mode of delivery on fetal pituitary-thyroid axis. Acta Paediatr Jpn 1991;33:363-8.  Back to cited text no. 17
[PUBMED]    
18. Fuse Y, Wakae E, Nemoto Y, Uga N, Tanaka M, Maeda M, et al. Influence of perinatal factors and sampling methods on TSH and thyroid hormone levels in cord blood. Endocrinol Jpn 1991;38:297-302.  Back to cited text no. 18
[PUBMED]    
19. Eun Young kim, Sang Kee Park, Chnag Hun Song, Sung-Chul Lim. Perinatal factors affecting thyroid stimulating hormone (TSH) and thyroid hormone levels in cord blood. Korean journal pediatrics 2005;48:143-7.  Back to cited text no. 19
    
20. Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Horm Res 1999;52:49-52.  Back to cited text no. 20
[PUBMED]    
21. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011;7:467-74.  Back to cited text no. 21
[PUBMED]    
22. Farrar D, Duley L, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev 2011;CD007122.  Back to cited text no. 22
    
23. Juretschke LJ. Apgar scoring: Its use and meaning for today's newborn. Neonatal Netw 2000;19:17-9.  Back to cited text no. 23
[PUBMED]    
24. Turan S, Bereket A, Angaji M, Koroglu OA, Bilgen H, Onver T, et al. The effect of the mode of delivery on neonatal thyroid function. J Matern Fetal Neonatal Med 2007;20:473-6.  Back to cited text no. 24
[PUBMED]    
25. Wang Y, Liu R, Guo J. Study on effect of delivery way on thyrotropin levels in pregnant women and their newborns. Zhonghua Fu Chan Ke Za Zhi 2001;36:282-4.  Back to cited text no. 25
[PUBMED]    
26. Belet N, Imdat H, Yanik F, Kucukoduk S. Thyroid function tests in preterm infants born to preeclamptic mothers with placental insufficiency. J Pediatr Endocrinol Metab 2003;16:1131-5.  Back to cited text no. 26
    
27. Chan LY, Chiu PY, Lau TK. Cord blood thyroid-stimulating hormone level in high-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 2003;108:142-5.  Back to cited text no. 27
[PUBMED]